Outlook Therapeutics, Inc. (OTLK)

0.4397 +0.03 (+6.98%) USD  |  NASDAQ  |  Feb 25, 16:00
0.4451 +0.01 (+1.23%) Pre-Market: 08:39
More

Outlook Therapeutics Accrued Expenses (Quarterly)

Accrued Expenses (Quarterly) Chart

View Accrued Expenses (Quarterly) for OTLK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Accrued Expenses (Quarterly) Range, Past 5 Years

View Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accrued Expenses (Quarterly) Benchmarks

View Accrued Expenses (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Neogen Corp. Upgrade
CorMedix, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade